skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,987  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: creation date: 1992 To 2008 remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Material Type:
Article 		Add to My Research

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4991-4997 [Peer Reviewed Journal]

2006 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2006.06.8429 ;PMID: 17075117

Full text available

Citations Cited by
2
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
Material Type:
Article 		Add to My Research

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2013-2019 [Peer Reviewed Journal]

2008 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.14.9930 ;PMID: 18421054

Full text available

Citations Cited by
3
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
Material Type:
Article 		Add to My Research

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.2006-2012 [Peer Reviewed Journal]

2008 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.14.9898 ;PMID: 18421053

Full text available

Citations Cited by
4
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
Material Type:
Article 		Add to My Research

Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia

Journal of clinical oncology, 2008-07, Vol.26 (19), p.3204-3212 [Peer Reviewed Journal]

2008 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.14.9260 ;PMID: 18541900

Full text available

Citations Cited by
5
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
Material Type:
Article 		Add to My Research

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3892-3901 [Peer Reviewed Journal]

2007 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2006.10.5460 ;PMID: 17679727

Full text available

Citations Cited by
6
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
Material Type:
Article 		Add to My Research

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.533-543 [Peer Reviewed Journal]

Springer Science+Business Media, LLC. 2008 ;2009 INIST-CNRS ;COPYRIGHT 2008 Springer ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-007-9885-0 ;PMID: 18188694 ;CODEN: BCTRD6

Full text available

Citations Cited by
7
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
Material Type:
Article 		Add to My Research

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7794-7803 [Peer Reviewed Journal]

2006 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2005.04.937 ;PMID: 16172456

Full text available

Citations Cited by
8
Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers
Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers
Material Type:
Article 		Add to My Research

Flux and age of dissolved organic carbon exported to the Arctic Ocean: A carbon isotopic study of the five largest arctic rivers

Global biogeochemical cycles, 2007-12, Vol.21 (4), p.GB4011-n/a [Peer Reviewed Journal]

2008 American Geophysical Union ;Copyright 2007 by the American Geophysical Union. ;2008 INIST-CNRS ;ISSN: 0886-6236 ;EISSN: 1944-9224 ;DOI: 10.1029/2007GB002934 ;CODEN: GBCYEP

Full text available

Citations Cited by
9
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
Material Type:
Article 		Add to My Research

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1545-1552 [Peer Reviewed Journal]

2007 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2005.05.1474 ;PMID: 17442998

Full text available

Citations Cited by
10
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Material Type:
Article 		Add to My Research

Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer

Annals of oncology, 2006-08, Vol.17 (8), p.1263-1268 [Peer Reviewed Journal]

2006 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdl104 ;PMID: 16740598

Full text available

Citations Cited by
11
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Material Type:
Article 		Add to My Research

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Annals of oncology, 2007-12, Vol.18 (12), p.1927-1934 [Peer Reviewed Journal]

2007 European Society for Medical Oncology ;2007 European Society for Medical Oncology 2007 ;2008 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdm201 ;PMID: 17998286

Full text available

Citations Cited by
12
Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study
Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study
Material Type:
Article 		Add to My Research

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5960-5972 [Peer Reviewed Journal]

2006 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2005.06.150 ;PMID: 16087945

Full text available

Citations Cited by
13
Acoustic characterization of high intensity focused ultrasound fields: A combined measurement and modeling approach
Acoustic characterization of high intensity focused ultrasound fields: A combined measurement and modeling approach
Material Type:
Article 		Add to My Research

Acoustic characterization of high intensity focused ultrasound fields: A combined measurement and modeling approach

The Journal of the Acoustical Society of America, 2008-10, Vol.124 (4), p.2406-2420 [Peer Reviewed Journal]

2008 Acoustical Society of America ;2008 INIST-CNRS ;Copyright © 2008 Acoustical Society of America 2008 Acoustical Society of America ;ISSN: 0001-4966 ;EISSN: 1520-8524 ;DOI: 10.1121/1.2967836 ;PMID: 19062878 ;CODEN: JASMAN

Full text available

Citations Cited by
14
Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation
Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation
Material Type:
Article 		Add to My Research

Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation

Nature genetics, 2007-04, Vol.39 (4), p.534-539 [Peer Reviewed Journal]

2007 INIST-CNRS ;COPYRIGHT 2007 Nature Publishing Group ;Copyright Nature Publishing Group Apr 2007 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/ng2013 ;PMID: 17384640 ;CODEN: NGENEC

Full text available

Citations Cited by
15
Impact of Inherited Thrombophilia on Venous Thromboembolism in Children : A Systematic Review and Meta-Analysis of Observational Studies
Impact of Inherited Thrombophilia on Venous Thromboembolism in Children : A Systematic Review and Meta-Analysis of Observational Studies
Material Type:
Article 		Add to My Research

Impact of Inherited Thrombophilia on Venous Thromboembolism in Children : A Systematic Review and Meta-Analysis of Observational Studies

Circulation (New York, N.Y.), 2008-09, Vol.118 (13), p.1373-1382 [Peer Reviewed Journal]

2008 INIST-CNRS ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.108.789008 ;PMID: 18779442 ;CODEN: CIRCAZ

Full text available

Citations Cited by
16
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
Material Type:
Article 		Add to My Research

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1301-1311 [Peer Reviewed Journal]

Copyright 2006 by Annals of the Rheumatic Diseases ;2006 INIST-CNRS ;Copyright: 2006 Copyright 2006 by Annals of the Rheumatic Diseases ;Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2006.055251 ;PMID: 16707533 ;CODEN: ARDIAO

Full text available

Citations Cited by
17
A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ) Randomized Controlled Trial
A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ) Randomized Controlled Trial
Material Type:
Article 		Add to My Research

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ) Randomized Controlled Trial

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1182-1192 [Peer Reviewed Journal]

2008 INIST-CNRS ;Copyright Nature Publishing Group May 2008 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1111/j.1572-0241.2007.01744.x ;PMID: 18371137

Full text available

Citations Cited by
18
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
Material Type:
Article 		Add to My Research

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

Nature genetics, 2006-12, Vol.38 (12), p.1397-1405 [Peer Reviewed Journal]

2007 INIST-CNRS ;COPYRIGHT 2006 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2006 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/ng1918 ;PMID: 17086182 ;CODEN: NGENEC

Full text available

Citations Cited by
19
First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study
First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study
Material Type:
Article 		Add to My Research

First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1178-1184 [Peer Reviewed Journal]

2005 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2005.09.102 ;PMID: 15718314

Full text available

Citations Cited by
20
Oral Health and Risk of Squamous Cell Carcinoma of the Head and Neck and Esophagus: Results of Two Multicentric Case-Control Studies
Oral Health and Risk of Squamous Cell Carcinoma of the Head and Neck and Esophagus: Results of Two Multicentric Case-Control Studies
Material Type:
Article 		Add to My Research

Oral Health and Risk of Squamous Cell Carcinoma of the Head and Neck and Esophagus: Results of Two Multicentric Case-Control Studies

American journal of epidemiology, 2007-11, Vol.166 (10), p.1159-1173 [Peer Reviewed Journal]

American Journal of Epidemiology © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. 2007 ;2008 INIST-CNRS ;American Journal of Epidemiology © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. ;ISSN: 0002-9262 ;EISSN: 1476-6256 ;DOI: 10.1093/aje/kwm193 ;PMID: 17761691 ;CODEN: AJEPAS

Full text available

Citations Cited by

Results 1 - 20 of 3,987  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,814)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1994  (202)
  2. 1994 To 1996  (272)
  3. 1997 To 1999  (494)
  4. 2000 To 2003  (818)
  5. After 2003  (2,202)
  6. More options open sub menu

Resource Type 

  1. Articles  (3,978)
  2. Conference Proceedings  (9)
  3. More options open sub menu

Language 

  1. English  (3,514)
  2. Japanese  (451)
  3. Serbian  (20)
  4. French  (11)
  5. Spanish  (4)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait